Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium: YAG laser ablation of the stratum corneum: continuous versus fractional ablation

Experimental Dermatology

Volumn 19, Issue 9, 2010, Pages 806-812

  Forster, Bernadette ^a   Klein, Annette ^a   Szeimies, Rolf Markus ^b   Maisch, Tim ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b Knappschaftskrankenhaus Recklinghausen   (Germany)

Author keywords

5 aminolaevulinic acid; Laser ablation; Photodynamic therapy; Protoporphyrin IX

Indexed keywords

ALUMINUM; AMINOLEVULINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ERBIUM YAG LASER; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HISTOLOGY; LASER SURGERY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; SKIN NECROSIS; SKIN PENETRATION; STRATUM CORNEUM;

AMINOLEVULINIC ACID; ANIMALS; EPIDERMIS; FEASIBILITY STUDIES; FEMALE; LASERS, SOLID-STATE; MICROSCOPY, FLUORESCENCE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SWINE;

EID: 77955751917     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2010.01093.x     Document Type: Article

References (21)

1. Fang J Y, Lee W R, Shen S C, Fang Y P, Hu C H. Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation. Br J Dermatol 2004, 151:132-140.
2. Gerritsen M J, Smits T, Kleinpenning M M, van de Kerkhof P C, van Erp P E. Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology 2009, 218:193-202.
3. Donelly R F, Morrow D I, McCarron P A. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. J Control Release 2008, 129:154-162.
4. Lopez R F, Bentley M V, Begoña Delgado-Charro M, Guy R H. Optimization of aminolevulinic acid delivery by iontophoresis. J Control Release 2003, 88:65-70.
5. Rhodes L E, Tsoukas M M, Anderson R R, Kollias N. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. J Invest Dermatol 1997, 108:87-91.
6. van den Akker J T, Boot K, Vernon D I. Effect of elevating the skin temperature during topical ALA application on in vitro ALA penetration through mouse skin and in vivo PpIX production in human skin. Photochem Photobiol Sci 2004, 3:263-267.
7. Johnson P G, Hui S W, Oseroff A R. Electrically enhanced percutaneous delivery of δ-aminolevulinic acid using electric pulses and a DC potential. Photochem Photobiol 2002, 75:534-540.
8. Maisch T, Santarelli F, Schreml S, Babilas P, Szeimies R M. Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model. Exp Dermatol 2009, http://dx.doi.org/10.1111/j.1600-0625.2009.01001.x, epub ahead: DOI:10.1111/j.1600-0625.2009.01001.x
9. Pudroma X, Moan J, Ma L W, Iani V, Juzeniene A. A comparison of 5-aminolaevulinic acid- and its heptyl ester: dark cytotoxicity and protoporphyrin IX synthesis in human adenocarcinoma WiDr cells and in athymic nude mice healthy skin. Exp Dermatol 2009, 18:985-987.
10. Drnovsek-Olup B, Vedlin B. Use of Er:YAG laser for benign skin disorder. Lasers Surg Med 1997, 21:3-19.
11. Lapidoth M, Yagima Odo M E, Odo L M. Novel use of Erbium:YAG (2,940-nm) laser for fractional ablative photothermolysis in the treatment of photodamaged facial skin: a pilot study. Dermatol Surg 2008, 34:1048-1053.
12. Lee W R, Shen S C, Lai H H, Hu C H, Fang J Y. Transdermal drug delivery enhanced and controlled by erbium:YAG laser: a comparative study of lipophilic and hydrophilic drugs. J Control Release 2001, 75:155-166.
13. Nelson J S, McCullough J L, Glenn T, Wright W H, Liaw L H, Jacques S L. Mid-infrared laser ablation of stratum corneum enhances in vitro percutaneous transport of drugs. J Invest Dermatol 1991, 97:874-879.
14. Maisch T, Worlicek C, Babilas P, Landthaler M, Szeimies R M. A HCl/alcohol formulation increased 5-aminolaevulinic acid skin distribution using an ex vivo full thickness porcine skin model. Exp Dermatol 2008, 17:813-820.
15. Maisch T, Bosl C, Szeimies R-M, Love B, Abels C. Determination of the antibacterial efficacy of a new porphyrin-based photosensitizer against MRSA ex vivo. Photochem Photobiol Sci 2007, 6:545-551.
16. Lee W R, Shen S C, Wang K H, Hu C H, Fang J Y. The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil. J Pharm Sci 2002, 91:1613-1626.
17. Jacques S L, McAuliffe D J, Blank I H, Parrish J A. Controlled removal of human stratum corneum by pulsed lasers. J Invest Dermatol 1987, 88:88-93.
18. Juzeniene A, Juzenas P, Ma L W, Iani V, Moan J. Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin. Br J Dermatol 2006, 155:791-799.
19. Shen S C, Lee W R, Fang Y P, Hu C H, Fang J Y. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolaevulinic acid application with enhancement using an erbium:YAG laser. J Pharm Sci 2006, 95:929-938.
20. Dickel H, Bruckner T M, Erdmann S M. The "strip" patch test: results of a multicentre study towards a standardization. Arch Dermatol Res 2004, 296:212-219.
21. Trelles M A, Velez M, Mordon S. Correlation of histological findings of single session Er:YAG skin fractional resurfacing with various passes and energies and the possible clinical implications. Lasers Surg Med 2008, 40:174-177.